BA
ABBV icon

Ballew Advisors’s AbbVie ABBV Stock Holding History

Ballew Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$460K Sell
1,751
-8
-0.5% -$2.05K 0.23% 83
2026
Q2 		$459K Buy
1,759
+6
+0.3% +$1.29K 0.24% 80
2026
Q1 		$372K Buy
1,753
+4
+0.2% +$887 0.21% 84
2025
Q4 		$386K Buy
1,749
+48
+3% +$10.9K 0.22% 81
2025
Q3 		$390K Buy
1,701
+376
+28% +$76.6K 0.22% 80
2025
Q2 		$251K Buy
1,325
+6
+0.5% +$1.11K 0.15% 99
2025
Q1 		$231K Buy
+1,319
New +$256K 0.15% 101
2024
Q4 		– Sell
-1,123
Closed -$219K – 105
2024
Q3 		$219K Buy
+1,123
New +$210K 0.15% 100
2018
Q4 		– Sell
-521
Closed -$42K – 93
2018
Q3 		$42K Buy
521
+3
+0.6% +$284 0.04% 172
2018
Q2 		$48K Buy
518
+3
+0.6% +$293 0.05% 158
2018
Q1 		$49K Buy
+515
New +$56.6K 0.04% 162

Other funds holding ABBV

HCM
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $880M AUM 10.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Ballew Advisors's ABBV Position: Q3 2026 in Review

Ballew Advisors reduced its AbbVie (ABBV) stake by 0.45% in Q3 2026, selling an estimated $2.05K and leaving 1,751 shares worth $460K. The position accounts for 0.23% of the portfolio, ranked #83.

Ballew Advisors first reported a position in ABBV in Q1 2018 and has held it in 11 quarters since. 246 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Ballew Advisors held 1,751 shares of AbbVie worth $460K as of Q3 2026.
  • Ballew Advisors sold 8 AbbVie shares in Q3 2026, an estimated $2.05K.
  • AbbVie made up 0.23% of Ballew Advisors's portfolio in Q3 2026, its #83 holding.
  • Ballew Advisors first reported a position in AbbVie in Q1 2018 and has held it in 11 quarters since.
  • 246 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Ballew Advisors's 13F filing for Q3 2026, filed 5 Oct 2026.